Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris

Mohsen Sharifi; Wassim Fares; Isam Abdel-Karim; J Michael Koch; Joseph Sopko; Dale Adler; Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions Investigators

doi:10.1016/j.amjcard.2004.03.009

Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris

Am J Cardiol. 2004 Jun 15;93(12):1533-5. doi: 10.1016/j.amjcard.2004.03.009.

Authors

Mohsen Sharifi¹, Wassim Fares, Isam Abdel-Karim, J Michael Koch, Joseph Sopko, Dale Adler; Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions Investigators

Affiliation

¹ Department of Cardiology, St. Vincent Charity Hospital, Case Western Reserve University and the University Hospital of Cleveland, Ohio, USA. mohsen.sharifi@ttuhsc.edu

PMID: 15194029
DOI: 10.1016/j.amjcard.2004.03.009

Abstract

The purpose of this trial was to assess whether the addition of hyperbaric oxygen to percutaneous coronary intervention can reduce clinical restenosis. Major adverse cardiac events at 8 months were found in only 1 of 24 patients (4%) who received hyperbaric oxygen compared with 13 of 37 patients (35%) who did not.

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Aged
Angina, Unstable / therapy*
Angioplasty, Balloon, Coronary*
Coronary Angiography
Coronary Restenosis / prevention & control*
Female
Humans
Hyperbaric Oxygenation*
Male
Middle Aged
Myocardial Infarction / therapy*
Treatment Outcome